Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
暂无分享,去创建一个
Xiaotu Ma | Jinghui Zhang | Scott Newman | Aman N. Patel | Matthew Parker | Susana Raimondi | Yuannian Jiao | Dale Hedges | Michael Rusch | Jared Becksfort | Erin K. Hedlund | John Easton | Yongjin Li | Sheila Shurtleff | Kohei Hagiwara | Aman Patel | David W Ellison | Michael F Walsh | Andrew Thrasher | Michael C. Rusch | Michael N. Edmonson | Erin Hedlund | J. Downing | S. Shurtleff | S. Raimondi | M. Edmonson | J. Klco | Yuannian Jiao | D. Ellison | J. Easton | Xiang Chen | Xiaotu Ma | D. Hedges | M. Rusch | D. Yergeau | Jinghui Zhang | J. Becksfort | Bhavin Vadodaria | Yanling Liu | M. Walsh | Yongjin Li | Zhaojie Zhang | Jiali Gu | G. Robinson | R. Tatevossian | J. Nakitandwe | Xiang Chen | Donald Yergeau | Bhavin Vadodaria | Jeffery M Klco | James R Downing | T. Gruber | Michael N Edmonson | Zhaojie Zhang | Ruth G Tatevossian | Yanling Liu | Joy Nakitandwe | Kohei Hagiwara | A. Thrasher | Tanja A Gruber | Giles W Robinson | Jiali Gu | James McMurry | Rose McGee | R. McGee | J. Mcmurry | Matthew Parker | S. Newman | Michael F. Walsh | J. Gu
[1] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[2] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[3] Joshua F. McMichael,et al. DNMT3A mutations in acute myeloid leukemia. , 2010, The New England journal of medicine.
[4] C. Sherr. A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6. , 2016, The New England journal of medicine.
[5] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[6] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[7] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[8] Florence I. Raynaud,et al. Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease , 2015, Cancer cell.
[9] C. Sander,et al. Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.
[10] M. K. Rudd,et al. Next-generation sequencing of duplication CNVs reveals that most are tandem and some create fusion genes at breakpoints. , 2015, American journal of human genetics.
[11] R. Finn,et al. Treating cancer with selective CDK4/6 inhibitors , 2016, Nature Reviews Clinical Oncology.
[12] J. Korbel,et al. Criteria for Inference of Chromothripsis in Cancer Genomes , 2013, Cell.
[13] Lessons Learned and Next Steps , 2016 .
[14] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[15] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[16] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[17] Z. Szallasi,et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Tao Wang,et al. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. , 2016, JAMA oncology.
[19] Li Ding,et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.
[20] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[21] Leming Shi,et al. Next-generation sequencing in the clinic: promises and challenges. , 2013, Cancer letters.
[22] R. Wilson,et al. Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data , 2012, Genome Biology.
[23] Peter Horak,et al. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls , 2016, ESMO Open.
[24] Michael C. Rusch,et al. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] E. Pleasance,et al. Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study. , 2016, Current oncology.
[26] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[27] Steven J. M. Jones,et al. Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing , 2015, PloS one.
[28] Aman N. Patel,et al. CONSERTING: integrating copy-number analysis with structural-variation detection , 2015, Nature Methods.
[29] Euan A Ashley,et al. Performance comparison of whole-genome sequencing platforms , 2011, Nature Biotechnology.
[30] Amar Gajjar,et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma , 2014, Nature Genetics.
[31] Dongfang Li,et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance , 2013, Nature Genetics.
[32] C. Brennan,et al. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. , 2010, Genes & development.
[33] Steven J. M. Jones,et al. BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data , 2012, Bioinform..
[34] Lee T. Sam,et al. Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.
[35] A. Chinnaiyan,et al. Precision medicine in pediatric oncology: Lessons learned and next steps , 2017, Pediatric blood & cancer.
[36] Kenneth H. Buetow,et al. Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .
[37] Ken Chen,et al. ClinSeK: a targeted variant characterization framework for clinical sequencing , 2015, Genome Medicine.
[38] Michael C. Rusch,et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.
[39] Savita Shrivastava,et al. Validation of a next-generation sequencing assay for clinical molecular oncology. , 2014, The Journal of molecular diagnostics : JMD.
[40] Alex M. Fichtenholtz,et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing , 2013, Nature Biotechnology.
[41] Steven J. M. Jones,et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.
[42] Andrew C. Wood,et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism , 2015, Nature.
[43] G. Sica,et al. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. , 2016, The Journal of molecular diagnostics : JMD.
[44] J. Lehmann-Che,et al. Resistance to therapy in acute promyelocytic leukemia. , 2014, The New England journal of medicine.
[45] Shinichi Morishita,et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults , 2016, Nature Genetics.
[46] Li Ding,et al. The Pediatric Cancer Genome Project , 2012, Nature Genetics.
[47] Winnie S. Liang,et al. A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges , 2013, PloS one.
[48] A. Ferrando,et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. , 2008, Blood.
[49] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[50] Eric E Schadt,et al. Analytical validation of whole exome and whole genome sequencing for clinical applications , 2014, BMC Medical Genomics.
[51] Richard Durbin,et al. Estimating telomere length from whole genome sequence data , 2014, Nucleic acids research.
[52] Heather L. Mulder,et al. Genomic landscape of pediatric adrenocortical tumors , 2015, Nature Communications.
[53] J. Khan,et al. MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research , 2016, Clinical Cancer Research.
[54] Donavan T. Cheng,et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.
[55] Heather L. Mulder,et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas , 2013, Nature Genetics.
[56] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[57] M. Loh,et al. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. , 2016, Cancer cell.
[58] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[59] Leslie G Biesecker,et al. Diagnostic clinical genome and exome sequencing. , 2014, The New England journal of medicine.
[60] Elaine R. Mardis,et al. Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.
[61] Heather L. Mulder,et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. , 2013, Cancer cell.
[62] Alessandro Romanel,et al. Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care , 2016, npj Genomic Medicine.
[63] B. Crompton,et al. Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study. , 2016, JAMA oncology.
[64] Winnie S. Liang,et al. Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers , 2016, Scientific Reports.
[65] Ken Chen,et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. , 2011, JAMA.
[66] Emmanuel C. Alozie,et al. Promises and Challenges , 2015 .